EXPRESSION OF CONCERN: Nitropravastatin Stimulates Reparative Neovascularisation and Improves Recovery from Limb Ischaemia in Type-1 Diabetic Mice

IF 7.7 2区 医学 Q1 PHARMACOLOGY & PHARMACY
{"title":"EXPRESSION OF CONCERN: Nitropravastatin Stimulates Reparative Neovascularisation and Improves Recovery from Limb Ischaemia in Type-1 Diabetic Mice","authors":"","doi":"10.1111/bph.70199","DOIUrl":null,"url":null,"abstract":"<p>\n <b>Expression of Concern:</b> <span>C. Emanueli</span>, <span>A. Monopoli</span>, <span>N. Kraenkel</span>, <span>M. Meloni</span>, <span>S. Gadau</span>, <span>I. Campesi</span>, <span>E. Ongini</span>, and <span>P. Madeddu</span>, “ <span>Nitropravastatin Stimulates Reparative Neovascularisation and Improves Recovery from Limb Ischaemia in Type-1 Diabetic Mice</span>,” <i>British Journal of Pharmacology</i> <span>150</span>, no. <span>7</span> (<span>2007</span>): <span>873</span>–<span>882</span>, https://doi.org/10.1038/sj.bjp.0707142</p><p>This Expression of Concern is for the above article, published online on 12 March 2007, in Wiley Online Library (http://onlinelibrary.wiley.com/), and has been issued by agreement between the journal Editor-in-Chief, Péter Ferdinandy; the British Pharmacological Society; and John Wiley &amp; Sons Ltd. The publisher received a report from a third party which indicated that two of the actin bands in Figure 5A showed evidence of splicing and duplication. An investigation by the publisher also detected these same concerns. The authors responded to an inquiry by the publisher and confirmed this duplication, as well as an additional error in Figure 6 where the Akt panels for pravastatin and NCX6550 had been swapped. The authors provided examples of the original western blot data and the densitometry data for the representative western blot images. They also requested a correction, to replace the erroneous images in Figures 5A and 6 with corrected representative western blots.</p><p>A review of these data by the journal editors found that, while the provided western blot data corresponded with the results presented in the article, the error bar of the published Statin graph in Figure 5B appeared to not match the quantification presented in the article. Additional concerns were raised that other data were included in the summary bar graph in addition to what was shown by the two representative immunoblots, but this was not clear based on the data provided. In response, the authors stated that the quantification shown in the graph should not be expected to derive from the densitometry data extracted from two samples based on other studies conducted at the author's institution during this period. However, original experimental records and data which would support this claim were no longer available due to the age of the article.</p><p>The parties have agreed that, based on the available data, they were not able to validate the data in Figure 5. Publishing a correction to replace the immunoblots in Figures 5A and 6 with corrected data was therefore not considered appropriate. The journal decided to issue this Expression of Concern to inform and alert the readers of the results of the investigation.</p><p>Author C. Emanueli disagrees with the Expression of Concern and stated that the densitometry performed on the provided bands was consistent with the published data, even though statistical significance was not achieved. Author P. Madeddu stated that the error had a minor impact on the main message considering that the key scientific data were confirmed later by other independent publications and that he has taken note of the exchange of correspondence regarding the case and stated his appreciation for the attempts of Prof. Emanueli and Dr. Meloni in searching for available data and trying to amend any possible error many years after publication. P. Madeddu further stated his support for the adoption of technology, not available to the authors at the time of publication of the article, which could help authors and reviewers in detecting errors of this kind during the revision stage. Authors N. Kraenkel, M. Meloni, S. Gadau, and I. Campesi were informed of the Expression of Concern. All other authors either could not be contacted or had passed away prior to the publication of the Expression of Concern.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":"182 20","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bph.70199","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70199","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Expression of Concern: C. Emanueli, A. Monopoli, N. Kraenkel, M. Meloni, S. Gadau, I. Campesi, E. Ongini, and P. Madeddu, “ Nitropravastatin Stimulates Reparative Neovascularisation and Improves Recovery from Limb Ischaemia in Type-1 Diabetic Mice,” British Journal of Pharmacology 150, no. 7 (2007): 873882, https://doi.org/10.1038/sj.bjp.0707142

This Expression of Concern is for the above article, published online on 12 March 2007, in Wiley Online Library (http://onlinelibrary.wiley.com/), and has been issued by agreement between the journal Editor-in-Chief, Péter Ferdinandy; the British Pharmacological Society; and John Wiley & Sons Ltd. The publisher received a report from a third party which indicated that two of the actin bands in Figure 5A showed evidence of splicing and duplication. An investigation by the publisher also detected these same concerns. The authors responded to an inquiry by the publisher and confirmed this duplication, as well as an additional error in Figure 6 where the Akt panels for pravastatin and NCX6550 had been swapped. The authors provided examples of the original western blot data and the densitometry data for the representative western blot images. They also requested a correction, to replace the erroneous images in Figures 5A and 6 with corrected representative western blots.

A review of these data by the journal editors found that, while the provided western blot data corresponded with the results presented in the article, the error bar of the published Statin graph in Figure 5B appeared to not match the quantification presented in the article. Additional concerns were raised that other data were included in the summary bar graph in addition to what was shown by the two representative immunoblots, but this was not clear based on the data provided. In response, the authors stated that the quantification shown in the graph should not be expected to derive from the densitometry data extracted from two samples based on other studies conducted at the author's institution during this period. However, original experimental records and data which would support this claim were no longer available due to the age of the article.

The parties have agreed that, based on the available data, they were not able to validate the data in Figure 5. Publishing a correction to replace the immunoblots in Figures 5A and 6 with corrected data was therefore not considered appropriate. The journal decided to issue this Expression of Concern to inform and alert the readers of the results of the investigation.

Author C. Emanueli disagrees with the Expression of Concern and stated that the densitometry performed on the provided bands was consistent with the published data, even though statistical significance was not achieved. Author P. Madeddu stated that the error had a minor impact on the main message considering that the key scientific data were confirmed later by other independent publications and that he has taken note of the exchange of correspondence regarding the case and stated his appreciation for the attempts of Prof. Emanueli and Dr. Meloni in searching for available data and trying to amend any possible error many years after publication. P. Madeddu further stated his support for the adoption of technology, not available to the authors at the time of publication of the article, which could help authors and reviewers in detecting errors of this kind during the revision stage. Authors N. Kraenkel, M. Meloni, S. Gadau, and I. Campesi were informed of the Expression of Concern. All other authors either could not be contacted or had passed away prior to the publication of the Expression of Concern.

Abstract Image

Abstract Image

Abstract Image

关注的表达:硝基普伐他汀刺激1型糖尿病小鼠的修复性新生血管并促进肢体缺血的恢复
关注表达:C. Emanueli, A. Monopoli, N. Kraenkel, M. Meloni, S. Gadau, I. Campesi, E. Ongini, P. Madeddu,“硝基普伐他汀刺激1型糖尿病小鼠肢体缺血的修复性新生血管和改善恢复,英国药理学杂志,150,no。7 (2007): 873-882, https://doi.org/10.1038/sj.bjp.0707142This对上述文章表示关注,该文章于2007年3月12日在线发表在Wiley在线图书馆(http://onlinelibrary.wiley.com/)上,并已由期刊主编psamuter Ferdinandy;英国药理学会;及约翰威利父子有限公司。出版商收到了一份来自第三方的报告,该报告指出,图5A中的两个肌动蛋白带显示了剪接和复制的证据。出版商的一项调查也发现了同样的担忧。作者回应了出版商的询问并确认了这一重复,以及图6中普伐他汀和NCX6550的Akt面板被交换的另一个错误。作者提供了具有代表性的western blot图像的原始数据和密度测量数据的例子。他们还要求进行更正,将图5A和图6中的错误图像替换为校正后的代表性western blots。期刊编辑对这些数据的回顾发现,虽然提供的western blot数据与文章中给出的结果相符,但图5B中已发表的他汀类药物图的误差条似乎与文章中给出的量化结果不匹配。除了两种具有代表性的免疫印迹所显示的数据外,还有其他数据被包括在汇总条形图中,但根据所提供的数据,这一点并不清楚。作为回应,作者指出,图表中所示的定量不应指望从基于作者所在机构在此期间进行的其他研究的两个样本中提取的密度测量数据中得出。然而,由于文章的年代久远,支持这一说法的原始实验记录和数据已不再可用。双方同意,基于可用的数据,他们无法验证图5中的数据。因此,用校正后的数据替换图5A和图6中的免疫印迹是不合适的。该杂志决定发表这份关注声明,以通知和提醒读者调查结果。作者C. Emanueli不同意the Expression of Concern的观点,他指出,在提供的波段上进行的密度测定与已发表的数据一致,尽管没有达到统计学意义。作者P. Madeddu说,考虑到关键的科学数据后来得到了其他独立出版物的证实,该错误对主要信息的影响很小,他注意到就该案件进行的通信交流,并表示他感谢Emanueli教授和Meloni博士在出版多年后搜索现有数据并试图修正任何可能的错误的努力。P. Madeddu进一步表示,他支持采用在文章发表时作者无法获得的技术,这可以帮助作者和审稿人在修改阶段发现这类错误。向作者N. Kraenkel、M. Meloni、S. Gadau和I. Campesi通报了关切表达。所有其他作者要么无法联系上,要么在《关切表达书》发表之前去世。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.40
自引率
12.30%
发文量
270
审稿时长
2.0 months
期刊介绍: The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信